Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

NCT00317226 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Ferric Carboxymaltose (FCM)

Sponsor

American Regent, Inc.